TABLE 2.
Oligonucleotides used in this study
| Designation | Source or reference | Sequence |
|---|---|---|
| 6 | This work | TAYGARTAYGAYTAYGGIAARGG |
| 7 | This work | TAYGAYTAYGGIAARGGIAARAARAC |
| 8 | This work | GAAGGCGGTTTCGATATTAAAGTGCC |
| 9 | This work | AAGAATGGATTTCTAAACAGGCTAC |
| 10 | This work | CTGGTTTAGCCAACCAATCAGCATTG |
| 11 | This work | CAATGCTGATTGGTTGGCTAAACCAG |
| 12 | This work | GTAAAGCGATCAGTAATGCGTGAGCC |
| 14 | This work | GACAGCATTCAGTGAATAATGGC |
| 16 | This work | GCGGCCGCTTAGAATTCATACCCAACAGAACCACC |
| 24 | This work | AATGAAGTCCGCACCTTTAACG |
| KS | Stratagene | TCGAGGTCGACGGTATC |
| T7 | Promoter, Novagen | TAATACGACTCACTATAGGG |